SCHEMBL6890833

SCHEMBL6890833

Oc1ccc(CF)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
DBH P09172 1/20 0.45
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 3/20 0.40
ADRA2A P08913 2/20 0.40
DRD2 P14416 2/20 0.40
DRD1 P21728 2/20 0.40
DRD4 P21917 2/20 0.40
DRD5 P21918 2/20 0.40
SLC6A2 P23975 2/20 0.40
MAPK1 P28482 2/20 0.40
DRD3 P35462 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL545298 0.83 CA1 (0.61) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL1338001 0.83 KDM4E (0.52) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL30058625 0.83 CA1 (0.61) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL1390780 0.81 CYP17A1 (0.46) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL30683156 0.81 CYP17A1 (0.46) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL15827407 0.81 CA6 (0.52) CA1CA2CA4CA6MAPT
SCHEMBL5071987 0.81 CYP17A1 (0.59) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL13351455 0.80 CA1 (0.64) CYP3A4CYP19A1CA1CA2CA4
SCHEMBL14802026 0.79 TAAR1 (0.48) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL3267119 0.79 ALOX15 (0.58) CYP19A1MAPTKDM4EADRA2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409441-B1 INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY MERCK PATENT GMBH (DE) 2009-11-18 EP disclosed
US-6677382-B1 HALOGENATED OXYAMINES, USED AS ENZYME INHIBITORS FOR PROPHYLAXIS OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISORDERS, AND AS ANTILIPEMIC AGENTS PHARMACIA CORPORATION 2004-01-13 US disclosed